For: | Palmieri G, Buonerba C, Federico P, Formisano L, Nappi L, Lorenzo GD, Marino M, Damiano V. Everolimus plus long-acting somatostatin analogs in thymic epithelial malignancies. World J Clin Oncol 2012; 3(7): 111-115 [PMID: 22787579 DOI: 10.5306/wjco.v3.i7.111] |
---|---|
URL: | https://www.wjgnet.com/2218-4333/full/v3/i7/111.htm |
Number | Citing Articles |
1 |
M. Kossai, B. Duchemann, C. Boutros, C. Caramella, A. Hollebecque, E. Angevin, A. Gazzah, R. Bahleda, E. Ileana, C. Massard, P. Vielh, J.C. Soria, B. Besse. Antitumor activity in advanced cancer patients with thymic malignancies enrolled in early clinical drug development programs (Phase I trials) at Gustave Roussy. Lung Cancer 2015; 89(3): 306 doi: 10.1016/j.lungcan.2015.06.014
|
2 |
Elif B. Köksoy, Hakan Akbulut. A late relapse thymoma and pure red cell aplasia case with an over 5 years of clinical response under everolimus. Anti-Cancer Drugs 2023; 34(10): 1193 doi: 10.1097/CAD.0000000000001504
|
3 |
Jennifer Wheler, David Hong, Stephen G. Swisher, Gerald Falchook, Apostolia M. Tsimberidou, Thorunn Helgason, Aung Naing, Bettzy Stephen, Filip Janku, Philip J. Stephens, Roman Yelensky, Razelle Kurzrock. Thymoma Patients Treated in a Phase I Clinic at MD Anderson Cancer Center: Responses to mTOR Inhibitors and Molecular Analyses. Oncotarget 2013; 4(6): 890 doi: 10.18632/oncotarget.1015
|
4 |
Fabio Conforti, Laura Pala, Giuseppe Giaccone, Tommaso De Pas. Thymic epithelial tumors: From biology to treatment. Cancer Treatment Reviews 2020; 86: 102014 doi: 10.1016/j.ctrv.2020.102014
|
5 |
Recent Advances in Pathologic Research and Targeted Therapies of Thymoma . Journal of Cancer Research Updates 2019; 8(1): 6 doi: 10.30683/1929-2279.2019.08.02
|
6 |
Liliana Montella, Margaret Ottaviano, Rocco Morra, Erica Pietroluongo, Pietro De Placido, Marianna Tortora, Chiara Sorrentino, Gaetano Facchini, Sabino De Placido, Mario Giuliano, Giovannella Palmieri. The Never-Ending History of Octreotide in Thymic Tumors: A Vintage or A Contemporary Drug?. Cancers 2022; 14(3): 774 doi: 10.3390/cancers14030774
|
7 |
Giovannella Palmieri, Carlo Buonerba, Margaret Ottaviano, Piera Federico, Filomena Calabrese, Claudia Von Arx, Ana Paula De Maio, Mirella Marino, Maurizio Lalle, Liliana Montella, Carmela Merola, Michele Milella, Marina Bergaglio, Giuseppe Di Lorenzo, Vincenzo Damiano. Capecitabine Plus Gemcitabine in Thymic Epithelial Tumors: Final Analysis of a Phase II Trial. Future Oncology 2014; 10(14): 2141 doi: 10.2217/fon.14.144
|
8 |
Yusuke Okuma, Yukio Hosomi, Satoshi Takahashi, Yoshiharu Maeda, Tatsuru Okamura, Tsunekazu Hishima. Response to Cytotoxic Chemotherapy in Patients Previously Treated With Palliative-Intent Chemotherapy for Advanced Thymic Carcinoma. Clinical Lung Cancer 2015; 16(3): 221 doi: 10.1016/j.cllc.2014.10.006
|
9 |
Fabio Conforti, Laura Pala, Tommaso De Pas, Yongfeng He, Giuseppe Giaccone. Investigational drugs for the treatment of thymic cancer: a focus on phase 1 and 2 clinical trials. Expert Opinion on Investigational Drugs 2022; 31(9): 895 doi: 10.1080/13543784.2022.2113373
|
10 |
Arun Rajan, Nicolas Girard, Alexander Marx. State of the Art of Genetic Alterations in Thymic Epithelial Tumors. Journal of Thoracic Oncology 2014; 9(9): S131 doi: 10.1097/JTO.0000000000000298
|
11 |
Elisabetta Kuhn, Carlo Pescia, Paolo Mendogni, Mario Nosotti, Stefano Ferrero. Thymic Epithelial Tumors: An Evolving Field. Life 2023; 13(2): 314 doi: 10.3390/life13020314
|
12 |
Kerim Kaban. Principles and Practice of Radiotherapy Techniques in Thoracic Malignancies. 2016; : 399 doi: 10.1007/978-3-319-28761-4_18
|
13 |
Paolo Andrea Zucali, Tommaso De Pas, Giovannella Palmieri, Adolfo Favaretto, Antonio Chella, Marcello Tiseo, Michele Caruso, Matteo Simonelli, Matteo Perrino, Fabio De Vincenzo, Francesca Toffalorio, Vincenzo Damiano, Giulia Pasello, Erika Garbella, Marco Ali, Fabio Conforti, Margaret Ottaviano, Angela Cioffi, Sabino De Placido, Laura Giordano, Monica Bertossi, Annarita Destro, Luca Di Tommaso, Armando Santoro. Phase II Study of Everolimus in Patients With Thymoma and Thymic Carcinoma Previously Treated With Cisplatin-Based Chemotherapy. Journal of Clinical Oncology 2018; 36(4): 342 doi: 10.1200/JCO.2017.74.4078
|